MicroRNA-based Drugs for Brain Tumours - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Journal Articles Trends in Cancer Year : 2018

MicroRNA-based Drugs for Brain Tumours

Abstract

MicroRNAs (miRNAs) are key regulatory elements coded by the genome. A single miRNA can downregulate expression of multiple genes involved in diverse functions. As cancer is a disease with multiple gene aberrations, developing novel approaches to identify and modulate miRNA-pathways may result in a breakthrough for cancer treatment. With a special focus on glioblastoma, this review provides an up-to-date understanding of miRNA biogenesis, role of miRNA in cancer resistance, essential tools for modulating miRNA expression, emerging list of clinically promising RNAi delivery systems and how they can be adapted for therapy.
Fichier principal
Vignette du fichier
GLIAD(Anthiya)2018Eq17.pdf (2.92 Mo) Télécharger le fichier
Origin Files produced by the author(s)
Loading...

Dates and versions

inserm-01691531 , version 2 (24-01-2018)
inserm-01691531 , version 1 (10-07-2019)

Identifiers

Cite

Shubaash Anthiya, Audrey Griveau, Claire Loussouarn, Patrick Baril, Martin Garnett, et al.. MicroRNA-based Drugs for Brain Tumours. Trends in Cancer, 2018, 4 (3), pp.222-238. ⟨10.1016/j.trecan.2017.12.008⟩. ⟨inserm-01691531v2⟩
667 View
1514 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More